Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Enzyme-Linked Immunosorbent Assay. Found 12 abstracts

Jung S, Allen N, Arslan AA, Baglietto L, Brinton LA, Egleston BL, Falk R, Fortner RT, Helzlsouer KJ, Idahl A, Kaaks R, Lundin E, Merritt M, Onland-Moret C, Rinaldi S, Sanchez MJ, Sieri S, Schock H, Shu XO, Sluss PM, Staats PN, Travis RC, Tjonneland A, Trichopoulou A, Tworoger S, Visvanathan K, Krogh V, Weiderpass E, Zeleniuch-Jacquotte A, Zheng W, Dorgan JF. Demographic, lifestyle, and other factors in relation to antimullerian hormone levels in mostly late premenopausal women. Fertility and sterility. 2017 Apr;107(4):1012-1022 e2.   PMCID: PMC5426228
Jiang WD, Huang RC, Duan CH, Fu LW, Xi Y, Yang YB, Yang WM, Yang DZ, Yang DH, Huang RP. Identification of Five Serum Protein Markers for Detection of Ovarian Cancer by Antibody Arrays. Plos One. 2013 Oct;8(10):e76795.   PMCID: PMC 3792870
Dorgan JF, Spittle CS, Egleston BL, Shaw CM, Kahle LL, Brinton LA. Assay reproducibility and within-person variation of Mullerian inhibiting substance. Fertility and sterility. 2010 Jun;94(1):301-4.   PMCID: PMC2876207
Yuan QA, Robinson MK, Simmons HH, Russeva M, Adams GP. Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning. Cancer immunology, immunotherapy : CII. 2008 Mar;57(3):367-78.
Gordon MS, Matei D, Aghajanian C, Matulonis UA, Brewer M, Fleming GF, Hainsworth JD, Garcia AA, Pegram MD, Schilder RJ, Cohn DE, Roman L, Derynck MK, Ng K, Lyons B, Allison DE, Eberhard DA, Pham TQ, Dere RC, Karlan BY. Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status. J Clin Oncol. 2006 Sep 10;24(26):4324-32.
Ramcharan J, Colleluori DM, Merkel G, Andrake MD, Skalka AM. Mode of inhibition of HIV-I integrase by a C-terminal domain-specific monoclonal antibody. RETROVIROLOGY . 2006 Jan;3:34.
Wen L, Brill-Dashoff J, Shinton SA, Asano M, Hardy RR, Hayakawa K. Evidence of marginal-zone B cell-positive selection in spleen.[see comment]. Immunity. 2005 Sep;23(3):297-308.
Schlienger K, Chu CS, Woo EY, Rivers PM, Toll AJ, Hudson B, Maus MV, Riley JL, Choi Y, Coukos G, Kaiser LR, Rubin SC, Levine BL, Carroll RG, June CH. TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients. Clin Cancer Res. 2003 Apr;9(4):1517-27.
Yi J, Cheng H, Andrake MD, Dunbrack RL, Roder H, Skalka AM. Mapping the epitope of an inhibitory monoclonal antibody to the C-terminal DNA-binding domain of HIV-1 integrase. The Journal of biological chemistry. 2002 Apr 05;277(14):12164-74.
Yang WL, Frucht H. Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells. Carcinogenesis. 2001 Sep;22(9):1379-83.
von Mehren M, Arlen P, Tsang KY, Rogatko A, Meropol N, Cooper HS, Davey M, McLaughlin S, Schlom J, Weiner LM. Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. Clin Cancer Res. 2000 Jun;6(6):2219-28.
Yi J, Arthur JW, Dunbrack RL, Skalka AM. An inhibitory monoclonal antibody binds at the turn of the helix-turn-helix motif in the N-terminal domain of HIV-1 integrase. The Journal of biological chemistry. 2000 Dec 08;275(49):38739-48.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Enzyme-Linked Immunosorbent Assay

Enzyme-Linked Immunosorbent Assay metabolism Female genetics Adult immunology US Gov't Support-PHS blood methods Middle Aged Non-US Gov't Support Monoclonal Antibodies Aged Human Flow Cytometry HIV Integrase chemistry therapeutic use Ovarian Neoplasms enzymology Antibody Specificity pharmacology Amino Acid Substitution Antineoplastic Agents Apoptosis Anti-Mullerian Hormone Mononuclear Leukocytes T-Lymphocytes biosynthesis Kinetics Epitopes physiology Sensitivity and Specificity Molecular Sequence Data Catalytic Domain Mass Spectrometry-Matrix-Assisted Laser Desorption-Ionization Molecular Models Pilot Projects Cell Line Male HIV-1 Alanine Time Factors Reproducibility of Results Antibodies Interferon Type II Tissue Inhibitor of Metalloproteinases me [Metabolism] Europe cdc Genes effects CD80 Antigens Down-Regulation Colorectal Neoplasms MHC Class I Genes Recombinant Proteins Case-Control Studies Predictive Value of Tests Autoantibodies Antimullerian hormone 0 (Autoantigens) Phenotype Phagocytosis United States Thiazoles Ultraviolet Rays Catalysis Cancer Vaccines Prostaglandin-Endoperoxide Synthase Carcinoembryonic Antigen Helix-Turn-Helix Motifs Immunoglobulin Fc Fragments Antigen Receptors-B-Cell Biomarkers Molecular Cloning Dendritic Cells Spleen diagnosis DNA Fragmentation Biological Markers classification Antibody Affinity Protein Conformation Thy-1 Antigens Platelet-Derived Growth Factor alpha Receptor Antigen 0 (Receptors-B-Cell) Protein Binding Antigen-Antibody Reactions Laboratory Techniques and Procedures Drug Dose-Response Relationship CA-125 Antigen Bacteriophages Synthetic Vaccines im [Immunology] Peptide Receptors Microarray Analysis Dimerization HT29 Cells Age Factors Biopsy Immunotherapy Middle Age reproductive factors Drug Synergism Cluster Analysis 0 (notch2 receptor) Tretinoin Multivariate Analysis toxicity 80 and over Aged Recombinant Fusion Proteins Non-US Gov't Research Support Peptide Library Peptide Fragments 0 (Autoantibodies) Neural Networks (Computer) Asia pathology Polyacrylamide Gel Electrophoresis Secondary Protein Structure Isoleucine Binding Sites cy [Cytology] use Site-Directed Mutagenesis Antibody Binding Sites Tumor Biomarkers demographic Cross-Sectional Studies Testosterone Congeners Young Adult Carrier Proteins Premenopause DNA-Binding Proteins therapy Proteomics Prospective Studies Treatment Outcome Viral DNA drug effects cytology therapeutic adverse Amino Acid Sequence Isoenzymes CD40 Ligand Neoplastic Gene Expression Regulation Adenocarcinoma Immunoglobulin G Cell Separation
Last updated on Monday, May 04, 2020